Advent International about to acquire Laboratorio Teuto for approximately $480m

Brazilian daily Estado do Sao Paulo reported that private equity Advent International is about to acquire Laboratorio Teuto Brasileiro, for approximately $480m (BRL1.5bn). Laboratorio Teuto is a leader in Latin America’s generics industry and is owned by Pfizer (40%) and the Melo family (60%). (Source Estado do Sao Paulo)